Masaki Mori

61.1k total citations · 5 hit papers
1.3k papers, 43.4k citations indexed

About

Masaki Mori is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masaki Mori has authored 1.3k papers receiving a total of 43.4k indexed citations (citations by other indexed papers that have themselves been cited), including 483 papers in Surgery, 434 papers in Molecular Biology and 422 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masaki Mori's work include Gastric Cancer Management and Outcomes (207 papers), Esophageal Cancer Research and Treatment (129 papers) and Esophageal and GI Pathology (91 papers). Masaki Mori is often cited by papers focused on Gastric Cancer Management and Outcomes (207 papers), Esophageal Cancer Research and Treatment (129 papers) and Esophageal and GI Pathology (91 papers). Masaki Mori collaborates with scholars based in Japan, United States and China. Masaki Mori's co-authors include Yuichiro� Doki, Koshi Mimori, Hiroshi Inoue, Shuji Takiguchi, Makoto Yamasaki, Fumiaki Tanaka, Hideshi Ishii, Kiyokazu Nakajima, Yukinori Kurokawa and Hidetoshi Eguchi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Masaki Mori

1.3k papers receiving 42.8k citations

Hit Papers

Long Noncoding RNA HOTAIR Regulates Polycom... 1996 2026 2006 2016 2011 1996 2009 2011 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers
    2011 1.1k citations Ryunosuke Kogo, Teppei Shimamura et al. Cancer Research profile →
  2. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
    1996 884 citations Hiroshi Inoue, Masaki Mori et al. profile →
  3. Epithelial–mesenchymal transition in cancer development and its clinical significance
    2009 636 citations Masaaki Iwatsuki, Koshi Mimori et al. profile →
  4. Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs
    2011 574 citations Norikatsu Miyoshi, Hideshi Ishii et al. profile →
  5. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
    2014 475 citations Hirofumi Yamamoto, Hideshi Ishii et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaki Mori Japan 93 21.3k 12.4k 12.0k 9.8k 9.6k 1.3k 43.4k
Holger Moch Switzerland 91 18.3k 0.9× 9.7k 0.8× 11.4k 1.0× 6.3k 0.6× 14.7k 1.5× 604 36.5k
Yuichiro� Doki Japan 82 13.1k 0.6× 7.9k 0.6× 11.2k 0.9× 13.0k 1.3× 10.9k 1.1× 1.4k 34.8k
Hiroyuki Aburatani Japan 98 24.4k 1.1× 7.6k 0.6× 8.4k 0.7× 3.6k 0.4× 6.1k 0.6× 531 38.1k
Peter ten Dijke Netherlands 130 40.4k 1.9× 6.9k 0.6× 12.5k 1.0× 4.7k 0.5× 5.9k 0.6× 487 57.0k
Ming‐Sound Tsao Canada 98 16.5k 0.8× 8.3k 0.7× 15.3k 1.3× 3.0k 0.3× 13.8k 1.4× 653 37.2k
W. Marston Linehan United States 113 22.2k 1.0× 13.0k 1.0× 7.5k 0.6× 7.9k 0.8× 20.9k 2.2× 586 44.9k
Ralph R. Weichselbaum United States 107 17.9k 0.8× 7.6k 0.6× 18.7k 1.6× 5.7k 0.6× 10.6k 1.1× 707 48.4k
Robert J. Coffey United States 98 16.7k 0.8× 6.4k 0.5× 7.8k 0.7× 5.9k 0.6× 4.0k 0.4× 416 34.1k
Carlos Cordon‐Cardo United States 129 41.4k 1.9× 12.8k 1.0× 22.8k 1.9× 7.7k 0.8× 11.0k 1.2× 564 68.1k
Anirban Maitra United States 115 26.6k 1.2× 14.4k 1.2× 25.8k 2.1× 8.6k 0.9× 4.9k 0.5× 564 51.1k

Countries citing papers authored by Masaki Mori

Since Specialization
Citations

This map shows the geographic impact of Masaki Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Mori more than expected).

Fields of papers citing papers by Masaki Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Mori. The network helps show where Masaki Mori may publish in the future.

Co-authorship network of co-authors of Masaki Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Mori. A scholar is included among the top collaborators of Masaki Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Mori. Masaki Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawazoe, Tetsuro, Hiroshi Saeki, Eiji Oki, et al.. (2020). Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation. Molecular Cancer Research. 18(12). 1876–1888. 6 indexed citations
2.
Koseki, Jun, Hidekazu Takahashi, Norikatsu Miyoshi, et al.. (2019). Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells. Cancer Research. 79(7). 1426–1437. 51 indexed citations
3.
Mizushima, Tsunekazu, Xin Wu, Akira Inoue, et al.. (2018). Photodynamic Therapy Using Indocyanine Green Loaded on Super Carbonate Apatite as Minimally Invasive Cancer Treatment. Molecular Cancer Therapeutics. 17(7). 1613–1622. 35 indexed citations
4.
Inoue, Akira, Tsunekazu Mizushima, Xin Wu, et al.. (2018). A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS -Mutant Colon Cancer Cells. Molecular Cancer Therapeutics. 17(5). 977–987. 30 indexed citations
5.
Sugase, Takahito, Tsuyoshi Takahashi, Satoshi Serada, et al.. (2017). SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma. Cancer Research. 77(24). 6975–6986. 37 indexed citations
6.
Takahashi, Hidekazu, Junichi Nishimura, Yoshinori Kagawa, et al.. (2015). Significance of Polypyrimidine Tract–Binding Protein 1 Expression in Colorectal Cancer. Molecular Cancer Therapeutics. 14(7). 1705–1716. 61 indexed citations
7.
Takeyama, Hiroshi, Hirofumi Yamamoto, Shinya Yamashita, et al.. (2014). Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer. Molecular Cancer Therapeutics. 13(4). 976–985. 64 indexed citations
8.
Iwaya, Takeshi, Takeo Fukagawa, Yutaka Suzuki, et al.. (2013). Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer. Clinical Cancer Research. 19(23). 6438–6449. 37 indexed citations
9.
Sugimura, Keijiro, Hiroshi Miyata, Koji Tanaka, et al.. (2012). Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 18(18). 5144–5153. 139 indexed citations
10.
Nishida, Naohiro, Koshi Mimori, Muller Fabbri, et al.. (2011). MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab. Clinical Cancer Research. 17(9). 2725–2733. 215 indexed citations
11.
Hamano, Rie, Hiroshi Miyata, Makoto Yamasaki, et al.. (2011). Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway. Clinical Cancer Research. 17(9). 3029–3038. 216 indexed citations
12.
Kogo, Ryunosuke, Koshi Mimori, Fumiaki Tanaka, Shizuo Komune, & Masaki Mori. (2011). Clinical Significance of miR-146a in Gastric Cancer Cases. Clinical Cancer Research. 17(13). 4277–4284. 179 indexed citations
13.
Kogo, Ryunosuke, Teppei Shimamura, Koshi Mimori, et al.. (2011). Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers. Cancer Research. 71(20). 6320–6326. 1070 indexed citations breakdown →
14.
Deguchi, Takashi, Masahiro Tanemura, Eiji Miyoshi, et al.. (2010). Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express α-Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer. Cancer Research. 70(13). 5259–5269. 50 indexed citations
15.
Uemura, Mamoru, Hirofumi Yamamoto, Ichiro Takemasa, et al.. (2010). Jumonji Domain Containing 1A Is a Novel Prognostic Marker for Colorectal Cancer: In vivo Identification from Hypoxic Tumor Cells. Clinical Cancer Research. 16(18). 4636–4646. 80 indexed citations
16.
Yokobori, Takehiko, Koshi Mimori, Masaaki Iwatsuki, et al.. (2009). p53 -Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases. Cancer Research. 69(9). 3788–3794. 126 indexed citations
17.
Ishii, Hideshi, Koshi Mimori, Kazuhiro Ishikawa, et al.. (2008). Fhit-Deficient Hematopoietic Stem Cells Survive Hydroquinone Exposure Carrying Precancerous Changes. Cancer Research. 68(10). 3662–3670. 14 indexed citations
18.
Yamashita, Keishi, Myoung Sook Kim, Hannah Lui Park, et al.. (2008). HOP/OB1/NECC1 Promoter DNA Is Frequently Hypermethylated and Involved in Tumorigenic Ability in Esophageal Squamous Cell Carcinoma. Molecular Cancer Research. 6(1). 31–41. 47 indexed citations
19.
Kim, Myoung Sook, Keishi Yamashita, Jin Hyen Baek, et al.. (2006). N- Methyl- d -Aspartate Receptor Type 2B Is Epigenetically Inactivated and Exhibits Tumor-Suppressive Activity in Human Esophageal Cancer. Cancer Research. 66(7). 3409–3418. 93 indexed citations
20.
Mori, Masaki, et al.. (1995). Chromogranin positive cells in colorectal carcinoma and transitional mucosa.. Journal of Clinical Pathology. 48(8). 754–758. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Holger Moch Breakdown of academic impact, for papers by Yuichiro� Doki Breakdown of academic impact, for papers by Hiroyuki Aburatani Breakdown of academic impact, for papers by Peter ten Dijke Breakdown of academic impact, for papers by Ming‐Sound Tsao Breakdown of academic impact, for papers by W. Marston Linehan Breakdown of academic impact, for papers by Ralph R. Weichselbaum Breakdown of academic impact, for papers by Robert J. Coffey Breakdown of academic impact, for papers by Carlos Cordon‐Cardo Breakdown of academic impact, for papers by Anirban Maitra
Rankless by CCL
2026